Fore Research & Management, LP - ISIS PHARMACEUTICALS INC DEL ownership

Quarter-by-quarter ownership
Fore Research & Management, LP ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q2 2015$22,020,000
-9.6%
6,331,0000.0%0.64%
-27.2%
Q1 2015$24,350,000
+3.4%
6,331,0000.0%0.88%
-30.9%
Q4 2014$23,555,000
-78.4%
6,331,000
-86.0%
1.28%
-60.3%
Q3 2014$109,189,000
+5.1%
45,073,000
-4.2%
3.21%
+8.1%
Q2 2014$103,854,000
-22.1%
47,073,000
-5.1%
2.97%
-31.6%
Q1 2014$133,379,000
+72.7%
49,618,000
+60.1%
4.34%
+45.3%
Q4 2013$77,229,000
+83.1%
31,000,000
+72.2%
2.99%
+12.8%
Q3 2013$42,176,00018,000,0002.65%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders